Professional Documents
Culture Documents
Multi-Scale Approaches in Drug Discovery. From Empirical Knowledge To in Silico Experiments and Back Alejandro Speck-Planche (Eds.)
Multi-Scale Approaches in Drug Discovery. From Empirical Knowledge To in Silico Experiments and Back Alejandro Speck-Planche (Eds.)
https://textbookfull.com/product/antidotes-to-toxins-and-drugs-
from-natural-sources-to-drug-discovery-in-toxicology-drug-
discovery-update-1st-edition-mihnea-alexandru-gaman/
https://textbookfull.com/product/innovative-approaches-in-drug-
discovery-ethnopharmacology-systems-biology-and-holistic-
targeting-1st-edition-bhushan-patwardhan/
https://textbookfull.com/product/allosterism-in-drug-discovery-
dario-doller/
https://textbookfull.com/product/bioinformation-discovery-data-
to-knowledge-in-biology-pandjassarame-kangueane/
Multi-Target Drug Design Using Chem-Bioinformatic
Approaches Kunal Roy
https://textbookfull.com/product/multi-target-drug-design-using-
chem-bioinformatic-approaches-kunal-roy/
https://textbookfull.com/product/symmetries-in-atomic-nuclei-
from-isospin-to-supersymmetry-alejandro-frank/
https://textbookfull.com/product/heterocyclic-chemistry-in-drug-
discovery-1st-edition-li/
https://textbookfull.com/product/synthetic-methods-in-drug-
discovery-volume-2-blakemore/
https://textbookfull.com/product/pharmaceuticals-from-microbes-
impact-on-drug-discovery-divya-arora/
Multi-Scale Approaches
in Drug Discovery
From Empirical Knowledge to In Silico
Experiments and Back
Edited by
Alejandro Speck-Planche
Elsevier
Radarweg 29, PO Box 211, 1000 AE Amsterdam, Netherlands
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
This book and the individual contributions contained in it are protected under copyright by
the Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional practices,
or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in
evaluating and using any information, methods, compounds, or experiments described
herein. In using such information or methods they should be mindful of their own safety and
the safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors,
assume any liability for any injury and/or damage to persons or property as a matter of
products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
ISBN: 978-0-08-101129-4
ix
Chapter 1
different targets require ligands with different binding mechanism, which will
possibly be mirrored by their thermodynamic profiles. A central nervous
system drug needs different properties when compared with a drug addressing
an extracellular target, e.g., a protease in the bloodstream. High target
selectivity can be of utmost importance to avoid undesirable side effects; by
contrast, promiscuous binding to several protein family members can be
essential to completely downregulate a particular biochemical pathway, e.g., in
case of kinases, or to achieve a well-balanced binding profile at a G-protein
coupled receptor. Rapid mutational changes of viral or bacterial targets can
create resistance against potent ligands. Pathogens follow this strategy by
creating, e.g., steric mismatch or changes in the protein dynamics to diminish
affinity of the bound active agent (Weber and Agniswamy, 2009; Ali et al.,
2010). As the molecular foundations of these mechanisms are quite distinct,
well-tailored thermodynamic signatures can be important to escape resistance.
Freire et al. suggested improved resistance susceptibility for enthalpically
optimized ligands exhibiting sufficient flexibility to evade geometrical modi-
fications of the mutated target protein (Freire, 2008; Ohtaka and Freire, 2005).
Equally well, ligands bind with entropic advantage (Fernandez et al., 2012)
owing to high residual mobility, which allows the adaptation of multiple
binding modes that may be beneficial to escape resistance development. This
has been demonstrated by the superior resistance susceptibility of dapivirine or
etravirine over other human immunodeficiency virus (HIV) reverse transcriptase
inhibitors (Das et al., 2005). To apply such strategies in future projects we first
need reliable access and interpretation of thermodynamic data. We therefore
want to review in this contribution first the importance of different thermody-
namic properties and how they can be determined by experimental methods.
Furthermore, not only the accuracy and reliability but also the limitations of the
experimental approaches to record thermodynamic data will be considered in
the following. Subsequently, on the basis of these insights, we will discuss the
thermodynamic signature across congeneric series of proteineligand complexes
to illustrate correlations between structure and thermodynamic profiles.
It indicates how well a system can absorb or release heat, thus it provides a
crude idea how many degrees of freedom are available in the system to dissipate
or store heat. Experimentally, DCp is available from ITC titrations performed at
different temperatures (Jelesarov and Bossard, 1999). However, this evaluation
and the subsequent interpretation run into similar complications as the van’t
Hoff evaluation. The considered multicomponent system as the formation of a
proteineligand complex is so complex, that even across a temperature range of
20e30K major structural changes will occur (e.g., already in the ubiquitously
present bulk water phase) that make DCp interpretations extremely challenging.
Consequently, it is usually rather problematic to discuss straightforward DCp
changes of a proteineligand complex system on molecular level, even though
convincing examples have been reported (Stegmann et al., 2009).
Biological
Medicinal
ΔG Other
°=
0
50
ΔG
°=
-6
0
-TΔS (kJ/mol)
0
enthalpy
-50
dominant
entropy
dominant
-100 -50 0
ΔH (kJ/mol)
FIGURE 1.1 Published isothermal titration calorimetry data plotted onto a DH/TDS diagram.
The diagram has been split into areas where enthalpy (green) or entropy (red) dominates the
Gibbs free energy of binding (DG). Along the main diagonal the scatter in DG from about 15
to 60 kJ/mol is found corresponding to the range accessible to medicinal chemistry. Perpen-
dicularly, the mutual scatter in enthalpy and entropy with opposing contributions to DG is
shown. It spreads across a very large range indicating intrinsic enthalpy/entropy compensation.
Data are classified for ligands coming from different sources; optimization resulting from
medicinal chemistry programs tend to improve for entropic reasons (blue dashed arrow). The
figure was taken with permission from Olsson, T.S.G., Williams, M.A., Pitt, W.R., Ladbury, J.E.,
2008. The thermodynamics of proteinligandinteractions and solvation: insights for ligand
design. J. Mol. Biol. 384, 1002e1017 with slight modifications.
-10
-20
-30
ΔG
-40
ΔH
-50
-TΔS
-60
FIGURE 1.2 Difference of the relative thermodynamic binding data (DDG, DDH, TDDS) of
five ligands (left to right) optimized by preorganizing their geometry in the protein-bound
conformation. In this figure as in all following ones the thermodynamic data, recorded at 25 C,
are shown in terms of histograms. The example shows that the glycine derivative (left) inhibits
thrombin much more potent than the proline analog (most right) mainly for entropic reasons.
Profiling Drug Binding by Thermodynamics Chapter j 1 25
aromatic moiety and, thereby, reduces the residual mobility of the P1 sub-
stituent even further. Remarkably, the m-F to m-Cl replacement is character-
ized by an affinity loss due to an enthalpic disadvantage and an entropic gain
(Fig. 1.9Cvi). Fluorine does not exhibit the positive tip for attractive electro-
static interactions. Due to its smaller size, augmented residual mobility is
observed for the fluorine derivative leading to an entropic benefit.
1 2
∆∆ G
∆∆ H
-T∆∆ S
X X
X X
X X
3 4
FIGURE 1.10 Ligand 1 (orange, upper left) lacking methyl and carboxylate group binds to
thermolysin (TLN) establishing an extensive water network wrapping around the terminal P20
group. Upon methylation 2 is produced (blue, upper right, superimposed with TLN-1) and a small
enthalpically favored affinity gain is experienced. Two water molecules (encircled and crossed in
blue) are displaced, whereas two new ones are entrapped (red), which form favorable contacts to
the newly attached methyl group. Modifying 2 further to 4 (green, lower right, superimposed with
TLN-3) by adding the charged carboxylate group results in a strong affinity gain overwhelmingly
for enthalpic reasons. Surprisingly, attachment of the carboxylate to 1 forming 3 (magenta, lower
left, superimposed with TLN-1) is responded by a very weak thermodynamic signature even
though three water molecules (black crosses) are replaced by the carboxylate group, and one water
molecule (cyan) is shifted to enable a contact with the introduced COO group. Finally adding the
methyl group to 3 featuring 4 recovers the thermodynamic profile expected for the carboxylate
attachment. Remarkably, in TLN-3 the water network wrapping around the P20 substituent is
broken (indicated by the dashed line), which is responded by a loss in affinity for enthalpic reasons.
Instead, entropy is less affected as the broken network sacrifices less residual mobility. In TLN-4
(green) the water network is sealed again and the sole methyl attachment rescues the entire affinity
gain with enthalpically favored signature.
Sub-Order 3. Brachyura.[147]
Tribe 1. Dromiacea.
All authorities are agreed that these[149] are the most primitive of
the Brachyura. In them the abdomen is much less reduced in both
sexes than in other Brachyura; there is a common orbitoantennary
fossa, into which eyes and antennae are withdrawn, instead of a
separate one on each side for each organ; the carapace is often much
elongated as in the Macrura and Anomura, and a number of other
anatomical characters might be mentioned which characterise the
Dromiacea as intermediate between the true Brachyura and the
lower forms. There are, however, two views as to the relationship of
the Dromiacea; Claus held that they proceeded from a Galatheid
stock, and hence that the development of the Brachyura ran through
an Anomurous strain; but Huxley, and latterly Bouvier,[150] adopt the
view that the Dromiacea are descended, not from the Galatheidae,
but direct from the Macrura, and especially from the Nephropsidea.
Special resemblances are found between the Jurassic Nephropsidae
and certain present day Dromiacea, e.g. Homolodromia paradoxa,
the detailed form of the carapace in the two cases being very similar.
It is, however, a little strange that in the Dromiacea we meet with the
same reduction and dorsal position of the last, or last two pairs of
thoracic limbs which we saw to be such a characteristic feature of the
Anomura, especially of the Galatheidae. In the Dromiacea these
limbs may be chelate, and they are used for attaching shells and
other bodies temporarily to the back. Must we suppose that this
resemblance to the Anomura is due to convergence, or that the
Nephropsidae, which gave rise to perhaps both Galatheidae and
Dromiacea, had this character, and that it has been subsequently lost
in the Macruran stock? We have already mentioned that the
Metazoaea of Dromia has not only a well-developed swimming third
maxillipede, but also a biramous first pereiopod, a character which
speaks strongly for Macruran affinities.
Fam. 1. Dromiidae.—The eyes and antennules are retractile into
orbits. The last two pairs of thoracic limbs are small, and held
dorsally. The sixth pair of pleopods are rudimentary or absent.
Homolodromia from West Indies, deep-sea. Dromia, widely
dispersed. D. vulgaris (Fig. 126) occurs on the English coasts.
Fam. 2. Dynomenidae.—Similar to the preceding family, but
only the last pair of thoracic limbs is small, and held dorsally. The
sixth pair of pleopods are
reduced, but always present.
Dynomene in the Indo-Pacific.
Fam. 3. Homolidae.—The
eyes and antennules are not
retractile into orbits. Only the last
pair of thoracic limbs are
reduced, the sixth pair of
pleopods altogether absent.
Fig. 126.—Dromia vulgaris, × 1. (After Homola and Latreillia, widely
Milne Edwards and Bouvier.) distributed, occur in the
Mediterranean. Latreillopsis
[151]
from the Pacific. L. petterdi, a magnificent species, with the
carapace nearly a foot long, and with very long legs like a Spider-
crab, has been dredged from 800 fathoms east of Sydney, New South
Wales.
Tribe 2. Oxystomata.
Tribe 3. Cyclometopa.
Tribe 4. Oxyrhyncha.